Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Epiglottitis D004826 1 associated lipids
Furcation Defects D017823 1 associated lipids
Pseudolymphoma D019310 1 associated lipids
Tenosynovitis D013717 3 associated lipids
Corneal Endothelial Cell Loss D055954 1 associated lipids
Asymptomatic Infections D058345 1 associated lipids
Aphasia, Broca D001039 1 associated lipids
Heartburn D006356 2 associated lipids
Eisenmenger Complex D004541 1 associated lipids
Focal Nodular Hyperplasia D020518 1 associated lipids
Splenic Diseases D013158 5 associated lipids
Trismus D014313 1 associated lipids
Male Urogenital Diseases D052801 1 associated lipids
Hyper-IgM Immunodeficiency Syndrome D053306 1 associated lipids
T-Lymphocytopenia, Idiopathic CD4-Positive D018344 1 associated lipids
Pyomyositis D052880 2 associated lipids
Myelitis, Transverse D009188 1 associated lipids
Hernia, Hiatal D006551 3 associated lipids
Achondroplasia D000130 1 associated lipids
Tracheobronchomalacia D055089 1 associated lipids
Reproductive Tract Infections D060737 1 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Pneumonia, Lipid D011017 2 associated lipids
Protozoan Infections D011528 6 associated lipids
Tick Bites D064927 1 associated lipids
Granulomatous Mastitis D058890 1 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
[Antibiotics in routine practice. With proper selection rapid success]. 2002 MMW Fortschr Med pmid:12532526
[Azithromycin for pediatric indications. Brief therapy is ideal for children]. 2002 MMW Fortschr Med pmid:12532527
Dakdouki GK et al. Azithromycin-induced rash in infectious mononucleosis. 2002 Scand. J. Infect. Dis. pmid:12587634
Ivashkin VT et al. Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. 2002 World J. Gastroenterol. pmid:12378634
Hook EW et al. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. 2002 Sex Transm Dis pmid:12172535
Ohrt C et al. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. 2002 Antimicrob. Agents Chemother. pmid:12121927
Gandhi R et al. Characterization of azithromycin hydrates. 2002 Eur J Pharm Sci pmid:12128172
Fulcher SF et al. Delayed-onset mycobacterial keratitis after LASIK. 2002 Cornea pmid:12131028
Gaynor BD et al. Rationale for mass antibiotic distribution for trachoma elimination. 2002 Int Ophthalmol Clin pmid:12189619
Fry AM et al. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. 2002 Clin. Infect. Dis. pmid:12145722
Shelby-James TM et al. Impact of single dose azithromycin on group A streptococci in the upper respiratory tract and skin of Aboriginal children. 2002 Pediatr. Infect. Dis. J. pmid:12150171
Davis JL et al. Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. 2002 J. Vet. Pharmacol. Ther. pmid:12000529
Ng LK et al. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. 2002 Antimicrob. Agents Chemother. pmid:12183262
Mandell GL and Coleman EJ Effect of antipyretic agents on uptake, transport, and release of antimicrobial agents by human polymorphonuclear leukocytes. 2002 J. Infect. Dis. pmid:12001049
Prunier AL et al. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. 2002 Antimicrob. Agents Chemother. pmid:12183270
Treadway G et al. The safety of azithromycin in the treatment of adults with community-acquired respiratory tract infections. 2002 Int. J. Antimicrob. Agents pmid:11932140
[Unfortunately without effectiveness: chlamydia eradication after infarct]. 2002 MMW Fortschr Med pmid:12014269
Suriawinata A and Min AD A 33-year-old woman with jaundice after azithromycin use. 2002 Semin. Liver Dis. pmid:12016551
Evans AT et al. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. 2002 Lancet pmid:12020525
King A et al. Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin. 2002 Clin. Microbiol. Infect. pmid:11952721
Kutlin A et al. Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model. 2002 J. Antimicrob. Chemother. pmid:12003969
Rustomjee R et al. A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. 2002 J. Antimicrob. Chemother. pmid:12003988
Voytilla KL et al. Visual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site delivery. 2002 Am J Health Syst Pharm pmid:12004465
Amsden GW et al. A study of the interaction potential of azithromycin and clarithromycin with atorvastatin in healthy volunteers. 2002 J Clin Pharmacol pmid:11936570
Lacroix JS et al. Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute rhinosinusitis. 2002 Acta Otolaryngol. pmid:11936912
Ghaffar F et al. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. 2002 Clin. Infect. Dis. pmid:11981724
Edelstein PH Predicting the emergence of antimicrobial resistance. 2002 Clin. Infect. Dis. pmid:11981741
Bosch-Driessen LH et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. 2002 Am. J. Ophthalmol. pmid:12095805
Champney WS and Miller M Inhibition of 50S ribosomal subunit assembly in Haemophilus influenzae cells by azithromycin and erythromycin. 2002 Curr. Microbiol. pmid:12000992
Butler T Reduction of MIC of azithromycin for Salmonella typhi and Staphylococcus aureus in broth exposed to previous growth of Salmonella typhi. 2002 J. Antimicrob. Chemother. pmid:12096025
White RL et al. Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000. 2002 Diagn. Microbiol. Infect. Dis. pmid:12106954
Jung R et al. Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila. 2002 J. Antimicrob. Chemother. pmid:12003984
Gaylor AS and Reilly JC Therapy with macrolides in patients with cystic fibrosis. 2002 Pharmacotherapy pmid:11837560
Muirhead GJ et al. The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers. 2002 Br J Clin Pharmacol pmid:11879258
Gomberg MA [Combined treatment of persisting urogenital chlamydia infection with sumamed and interferon alfa]. 2002 Antibiot. Khimioter. pmid:12365322
Hammerschlag MR Effect of azithromycin on endothelial function of patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. 2002 Circulation pmid:12370232
Adimora AA Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. 2002 Clin. Infect. Dis. pmid:12353204
Augenbraun MH Treatment of syphilis 2001: nonpregnant adults. 2002 Clin. Infect. Dis. pmid:12353205
Itoh M et al. [A case of immotile-dyskinetic cilia syndrome responding to clenbuterol hydrochloride and azithromycin]. 2002 Nihon Kokyuki Gakkai Zasshi pmid:12382429
Equi A et al. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. 2002 Lancet pmid:12383667
Ohara T et al. Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response. 2002 Antimicrob. Agents Chemother. pmid:12384353
Sullivan B et al. Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. 2002 Am. J. Gastroenterol. pmid:12385435
Brook I Antibacterial therapy for acute group a streptococcal pharyngotonsillitis: short-course versus traditional 10-day oral regimens. 2002 Paediatr Drugs pmid:12390046
Tambiah J and Powell JT Chlamydia pneumoniae antigens facilitate experimental aortic dilatation: prevention with azithromycin. 2002 J. Vasc. Surg. pmid:12422113
Arnez M et al. Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin. 2002 Wien. Klin. Wochenschr. pmid:12422590
Maraspin V et al. Development of erythema migrans in spite of treatment with antibiotics after a tick bite. 2002 Wien. Klin. Wochenschr. pmid:12422612
Hall IH et al. Disposition and intracellular activity of azithromycin in human THP-1 acute monocytes. 2002 Int. J. Antimicrob. Agents pmid:12431870
Wolter JM et al. Macrolides in cystic fibrosis: is there a role? 2002 Am J Respir Med pmid:14720043
Nagai K et al. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. 2002 Antimicrob. Agents Chemother. pmid:11796375
Vorbach H et al. Endothelial cell compatibility of azithromycin and erythromycin. 2002 J. Antimicrob. Chemother. pmid:11815590
Krudsood S et al. A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria. 2002 Southeast Asian J. Trop. Med. Public Health pmid:12693587
Burton MJ et al. Azithromycin for the treatment and control of trachoma. 2002 Expert Opin Pharmacother pmid:11829725
Ohara T et al. [Protective effect of azithromycin against verotoxin]. 2002 Kansenshogaku Zasshi pmid:11905000
Salaria M and Singh M Atypical pneumonia in children. 2002 Indian Pediatr pmid:11910135
Desta Z et al. In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin. 2002 J Clin Psychopharmacol pmid:11910261
Ito N and Kudo S [Case of polycystic lung disease with mixed infections due to Aspergillus and Mycobacterium fortuitum successfully treated by AZM]. 2002 Jpn J Antibiot pmid:12664928
Kim MK et al. Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model. 2002 Antimicrob. Agents Chemother. pmid:12234843
Smith SR et al. A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results. 2002 J. Clin. Periodontol. pmid:11846850
Milberg P et al. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes. 2002 J. Pharmacol. Exp. Ther. pmid:12235254
Wu ML et al. Enterocolonic Mycobacterium avium-intracellulare. 2002 Arch. Pathol. Lab. Med. pmid:11860323
Cascio A and Colomba C [Macrolides in the treatment of children with Mediterranean spotted fever]. 2002 Infez Med pmid:12704264
Parchure N et al. Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. 2002 Circulation pmid:11901039
SoRelle R Treatment with azithromycin improves endothelial function. 2002 Circulation pmid:11902195
Firsov AA et al. Comparative pharmacodynamics of azithromycin and roxithromycin with S. pyogenes and S. pneumoniae in a model that simulates in vitro pharmacokinetics in human tonsils. 2002 J. Antimicrob. Chemother. pmid:11751774
Zubata P et al. A new HPLC method for azithromycin quantitation. 2002 J Pharm Biomed Anal pmid:11814725
Lentino JR and Krasnicka B Association between initial empirical therapy and decreased length of stay among veteran patients hospitalized with community acquired pneumonia. 2002 Int. J. Antimicrob. Agents pmid:11814769
Phillips P et al. Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program. 2002 Clin. Infect. Dis. pmid:11774085
Lau CY and Qureshi AK Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. 2002 Sex Transm Dis pmid:12218839
Culić O et al. Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. 2002 Eur. J. Pharmacol. pmid:12208321
Silva FM et al. Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer. 2002 Jan-Feb Rev Hosp Clin Fac Med Sao Paulo pmid:12170343
Kadappu KK et al. Azithromycin as treatment for cryptosporidiosis in human immunodeficiency virus disease. 2002 Jul-Sep J Postgrad Med pmid:12432190
Yaqubi GH and Anani GR Prevalence of trachoma in chronic conjunctivitis, Birjand, Islamic Republic of Iran. 2002 Mar-May East. Mediterr. Health J. pmid:15339124
Basilion EV et al. Height as a proxy for weight in determining azithromycin treatment for paediatric trachoma. 2002 Nov-Dec Trans. R. Soc. Trop. Med. Hyg. pmid:12625152
Mileusnic D et al. Pathological case of the month: sudden death in a child as a result of pancreatitis during valproic acid therapy. 2002 Sep-Oct Pediatr Pathol Mol Med pmid:12396903
Mesa FL et al. Antibiotic treatment of incipient drug-induced gingival overgrowth in adult renal transplant patients. 2003 J. Periodont. Res. pmid:12608908
[Uncomplicated community-acquired pneumonia. Under control in 3 treatment days]. 2003 MMW Fortschr Med pmid:12619240
Arreaza L et al. Emergence of gonococcal strains with resistance to azithromycin in Spain. 2003 J. Antimicrob. Chemother. pmid:12493814
Adachi JA et al. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. 2003 Clin. Infect. Dis. pmid:14557959
Schriever C et al. Red wine, resveratrol, Chlamydia pneumoniae and the French connection. 2003 Atherosclerosis pmid:14644410
Jennings MB et al. Comparison of azithromycin and cefadroxil for the treatment of uncomplicated skin and skin structure infections. 2003 Cutis pmid:14533837
Callaghan R and Allen M Mycobacterium malmoense infection of the knee. 2003 Ann. Rheum. Dis. pmid:14583565
Niederman MS [Conservative use of antibiotics is important, but: "Resistance hysteria is exaggerated"]. 2003 MMW Fortschr Med pmid:14584217
Al-Belasy FA and Hairam AR The efficacy of azithromycin in the treatment of acute infraorbital space infection. 2003 J. Oral Maxillofac. Surg. pmid:12618970
Dunne MW et al. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media. 2003 J. Antimicrob. Chemother. pmid:12888586
Rush C and Simon MW The effect of amoxicillin-clavulanate, cefixime and azithromycin on normal throat flora in children with group A streptococcal pharyngitis. 2003 Clin Pediatr (Phila) pmid:12862350
Lildholdt T et al. The natural history of recurrent acute tonsillitis and a clinical trial of azithromycin for antibiotic prophylaxis. 2003 Clin Otolaryngol Allied Sci pmid:12871256
Crum NF et al. Halting a pneumococcal pneumonia outbreak among United States Marine Corps trainees. 2003 Am J Prev Med pmid:12880877
Bhattacharya MK et al. Azithromycin in the treatment of cholera in children. 2003 Acta Paediatr. pmid:12856976
Favre-Bonté S et al. Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. 2003 J. Antimicrob. Chemother. pmid:12951348
Carryn S et al. Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model. 2003 J. Antimicrob. Chemother. pmid:12654747
Danesi R et al. Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg. 2003 J. Antimicrob. Chemother. pmid:12654753
Zhanel GG et al. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations. 2003 J. Antimicrob. Chemother. pmid:12775677
Blandford JM and Gift TL The cost-effectiveness of single-dose azithromycin for treatment of incubating syphilis. 2003 Sex Transm Dis pmid:12782951
Abdelghaffar H et al. Interaction of macrolides and ketolides with the phagocytic cell line PLB-985. 2003 J Chemother pmid:12962363
Castaldo RS et al. A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease. 2003 Clin Ther pmid:12749513
Skerk V et al. Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. 2003 Int. J. Antimicrob. Agents pmid:12727080
Trad O et al. Eradication of Cryptosporidium in four children with acute lymphoblastic leukemia. 2003 J. Trop. Pediatr. pmid:12729299
Zhou WQ et al. [Clinic efficacy of treating chronic prostatitis caused by Neisseria gonorrhoeae with azithromycin aspartic-acid injection]. 2003 Zhonghua Nan Ke Xue pmid:12680331
Sicklinger M et al. In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto. 2003 J. Clin. Microbiol. pmid:12682190
Ioannidis J and Wilkinson D HIV: prevention of opportunistic infections. 2003 Clin Evid pmid:15555123